Home › Funds › Hunting Hill Global Capital, LLC › ALNY

Hunting Hill Global Capital, LLC position in ALNY

ALNYLAM PHARMACEUTICALS INC · Health Care

Hunting Hill Global Capital, LLC reported holding 2,034 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q1 2026 13F filing — a position valued at US$673K, representing 0.72% of its reported portfolio and ranking #28 among its reported holdings. Hunting Hill Global Capital, LLC has disclosed ALNY holdings in 2 of the last 2 reported quarters, going back to Q4 2025.

Latest position (Q1 2026)2.03K sh
Reported value held$672.99K
Portfolio Weight0.72%
First reportedQ4 2025
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Hunting Hill Global Capital, LLC's ALNY position evolved

Hunting Hill Global Capital, LLC first disclosed a stake in ALNY in Q4 2025 at 4,259 shares (US$1.7M). Across 2 filings, Hunting Hill Global Capital, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 2,034 shares valued at US$673K — a reduction of -2,225 shares quarter over quarter.. Notable position changes include a 52% trim in Q1 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 4.26K $1.69M New
Q1 2026 2.03K $672.99K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALNY and 13F data

ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$734.5M), Orbis Allan Gray Ltd (US$598.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALNY

All ALNY fund holders →

FAQ

How long has Hunting Hill Global Capital, LLC held ALNY?

Hunting Hill Global Capital, LLC has disclosed ALNY holdings in 2 of the last 2 reported quarters, going back to Q4 2025.

What is Hunting Hill Global Capital, LLC's current position in ALNY?

As of Q1 2026, Hunting Hill Global Capital, LLC holds 2.03K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $672.99K, representing 0.72% of its reported portfolio and ranking #28.

Has Hunting Hill Global Capital, LLC been buying or selling ALNY?

In the latest 13F filing (Q1 2026), Hunting Hill Global Capital, LLC reduced its position in ALNY.

Which other funds hold ALNY?

Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.